Net Cash Provided by (Used in) Financing Activities of Strata Critical Medical, Inc. from 30 Sep 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Strata Critical Medical, Inc. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Sep 2019 to 31 Dec 2025.
  • Strata Critical Medical, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $4,246,000, a 7963% decline year-over-year.
  • Strata Critical Medical, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $8,912,000, a 55% decline from 2024.
  • Strata Critical Medical, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $5,759,000, a 7478% decline from 2023.
  • Strata Critical Medical, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $76,000, a 93% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

Strata Critical Medical, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $8,912,000 -$3,153,000 -55% 01 Jan 2025 31 Dec 2025 10-K 03 Mar 2026 2025 FY
2024 $5,759,000 -$5,683,000 -7478% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2026 2025 FY
2023 $76,000 +$1,008,000 +93% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $1,084,000 -$333,343,000 -100% 01 Jan 2022 31 Dec 2022 10-K 12 Mar 2024 2023 FY
2021 $332,259,000 +$331,079,000 +28058% 01 Oct 2020 30 Sep 2021 10-K 16 Mar 2023 2022 FY
2020 $1,180,000 +$1,064,000 +917% 01 Oct 2019 30 Sep 2020 10-K 20 Dec 2021 2021 FY
2019 $116,000 01 Oct 2018 30 Sep 2019 10-K 20 Dec 2021 2021 FY

Strata Critical Medical, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $4,246,000 -$4,300,000 -7963% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q1 2024 $54,000 +$81,000 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q1 2023 $27,000 -$43,000 -269% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $16,000 +$1,769,000 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $2,960,000 -$1,559,000 -111% 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q1 2021 $1,753,000 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $1,401,000 01 Oct 2020 31 Dec 2020 8-K 10 Jan 2023
Q3 2019 $276,820,486 24 May 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.